India’s Strides Arcolab Limited Gets US Nod For HIV Tab Nevirapine

August 16, 2006 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

MUMBAI, Aug 16 (Reuters) - India's Strides Arcolab Ltd. (STAR.BO: Quote, Profile, Research) said on Wednesday it had received tentative approval from the U.S. Food and Drug Administration for its HIV drug nevirapine in tablet forms.

Twitter
LinkedIn
Facebook
Email
Print

Regulatory Asia